Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia is the indication for 6 drugs in DrugBank. It is covered by 10 curated, structured indications.

Also known as: Waldenstrom Macroglobulinemia · Lymphoplasmacytoid lymphomas/immunocytomas · Waldenstrom's macroglobulinaemias · Waldenström Macroglobulinemia · Lymphoplasmacytic Lymphoma
Classified under: Cardiovascular Diseases
Hemic and Lymphatic Diseases
Immune System Diseases
Neoplasms
Indicated drugs: Bendamustine
Chlorambucil
Doxorubicin
Ibrutinib
Thalidomide
Zanubrutinib

Resolves to

Vocabularies

MeSHM0012865ICD-10C83.0SNOMED CT109981009MedDRA10025343UMLSC0024419

What you can answer from here — as of September 30, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

10Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

507Clinical trialsPhase, status and sponsor resolved per trial

3Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Waldenstrom's Macroglobulinemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.